Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences?
S Das, A Dasari - Current oncology reports, 2021 - Springer
Abstract Purpose of Review The purpose of our review is to explore global epidemiologic
trends of gastroenteropancreatic (GEP) neuroendocrine tumors (NETs). Specifically, we …
trends of gastroenteropancreatic (GEP) neuroendocrine tumors (NETs). Specifically, we …
Recent updates on grading and classification of neuroendocrine tumors
JY Kim, SM Hong, JY Ro - Annals of diagnostic pathology, 2017 - Elsevier
Neuroendocrine tumors (NETs) are originating from neuroendocrine cells in diffuse
endocrine systems. NETs are diagnosed by characteristic histologic features and …
endocrine systems. NETs are diagnosed by characteristic histologic features and …
ENETS consensus guidelines update for the management of patients with functional pancreatic neuroendocrine tumors and non-functional pancreatic neuroendocrine …
Only advances that occurred from 2011 to 2014 that either strengthen the previous 2011
guidelines [1, 2] or lead to changes or additional guidelines are reviewed here. Advances …
guidelines [1, 2] or lead to changes or additional guidelines are reviewed here. Advances …
Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based study
BE White, B Rous, K Chandrakumaran… - The Lancet Regional …, 2022 - thelancet.com
Background Neuroendocrine neoplasia (NEN) incidence is rising internationally. We aimed
to evaluate the epidemiology of NEN in England and examine changes in survival over time …
to evaluate the epidemiology of NEN in England and examine changes in survival over time …
Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis
T Ito, H Igarashi, K Nakamura, H Sasano… - Journal of …, 2015 - Springer
Abstract Background Although neuroendocrine tumors (NETs) are rare, the number of
patients with NET is increasing. However, in Japan, there have been no epidemiological …
patients with NET is increasing. However, in Japan, there have been no epidemiological …
Gastroenteropancreatic high‐grade neuroendocrine carcinoma
H Sorbye, J Strosberg, E Baudin, DS Klimstra, JC Yao - Cancer, 2014 - Wiley Online Library
Gastroenteropancreatic (GEP) neuroendocrine neoplasms are classified as low‐grade,
intermediate‐grade, and high‐grade tumors based on morphologic criteria and the …
intermediate‐grade, and high‐grade tumors based on morphologic criteria and the …
Recent updates on neuroendocrine tumors from the gastrointestinal and pancreatobiliary tracts
JY Kim, SM Hong - Archives of pathology & laboratory …, 2016 - meridian.allenpress.com
Context.—Gastrointestinal (GI) and pancreatobiliary tracts contain a variety of
neuroendocrine cells that constitute a diffuse endocrine system. Neuroendocrine tumors …
neuroendocrine cells that constitute a diffuse endocrine system. Neuroendocrine tumors …
Epidemiology of gastroenteropancreatic neuroendocrine tumours
M Fraenkel, MK Kim, A Faggiano, GD Valk - Best practice & research …, 2012 - Elsevier
Gastroenteropancreatic neuroendocrine tumours are a heterogeneous group of tumours
arising from diffuse endocrine cells, causing unique clinical syndromes. These tumours …
arising from diffuse endocrine cells, causing unique clinical syndromes. These tumours …
[HTML][HTML] Management of gastric and duodenal neuroendocrine tumors
Y Sato, S Hashimoto, K Mizuno… - World journal of …, 2016 - ncbi.nlm.nih.gov
Gastrointestinal neuroendocrine tumors (GI-NETs) are rare neoplasms, like all NETs.
However, the incidence of GI-NETS has been increasing in recent years. Gastric NETs (G …
However, the incidence of GI-NETS has been increasing in recent years. Gastric NETs (G …
Update on epidemiology, diagnosis, and biomarkers in gastroenteropancreatic neuroendocrine neoplasms
D Takayanagi, H Cho, E Machida, A Kawamura… - Cancers, 2022 - mdpi.com
Simple Summary Neuroendocrine neoplasms are divided into two groups: well-
differentiated neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas …
differentiated neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas …